“The only constant in life is change”— these words of wisdom from the ancient Greek philosopher Heraclitus pretty much resonates most with the pharmaceutical sector, where change is crucial for survival. The race for an effective cure across complex therapeutic areas and individual diseases is highly competitive, placing enormous pressure squarely on the drug development space. While the past decade has witnessed significant technological innovation in this space, particularly around artificial intelligence (AI) and machine learning aimed at streamlining and removing risks from the drug development process, this is only just the beginning.
Rapid growth in computer-processing power and the abundance of big data sets and advanced algorithms have brought ‘narrow-AI’ – which focuses on solving very specific problems and tasks – into existence across the pharmaceutical domain. This has triggered an explosive growth of AI applications in drug discovery, most often by identifying patterns hidden within large volumes of data. As a result, artificial intelligence is expected to make the hunt for new pharmaceuticals quicker and cheaper while adding a sense of certainty to the initial stages of drug development.
At this juncture, numerous innovative drug development solution providers and services are entering the domain with advanced and integrated offerings. On that note, to help the pharmaceutical sector strengthen its operational capabilities, a distinguished panel of CEOs, CIOs, VCs, and other thought leaders from the industry, along with the editorial board of Pharma Tech Outlook, has selected the leading drug discovery and development companies who can help pharma companies expedite the drug development process, and enable growth in the industry.
We present to you Pharma Tech Outlook’s ‘Top 10 Drug Discovery and Development Companies in UK - 2021
